Evidence map›Paper›PMID 30414380›Full record

ArticleBritish journal of pharmacology2019

Th1-type immune responses to Porphyromonas gingivalis antigens exacerbate angiotensin II-dependent hypertension and vascular dysfunction.

Marta Czesnikiewicz-Guzik, Ryszard Nosalski, Tomasz P Mikolajczyk, Francesca Vidler, Tomasz Dohnal, Elzbieta Dembowska, Delyth Graham, David G Harrison, Tomasz J Guzik

Open access · hybridAbstract read
In one paragraph

Article in British journal of pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 56 citations in OpenAlex.

  1. Effect of periodontal treatments on blood pressure.The Cochrane database of systematic reviews · 2021
    Pooled it
  2. Trial
  3. Article
  4. Review
  5. Saliva-driven surface-engineeredBioactive materials · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Oral microbiota in cardiovascular health and disease.Frontiers in cellular and infection microbiology · 2025
    Review
  12. Article
  13. Review
  14. Observational
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Marta Czesnikiewicz-GuzikDepartment of Periodontology and Oral Sciences Research Group, University of Glasgow Dental School and Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK.ORCID 0000-0002-7444-1373
Ryszard NosalskiInstitute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
Tomasz P MikolajczykInstitute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
Francesca VidlerInstitute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
Tomasz DohnalDepartment of Dental Prophylaxis and Experimental Dentistry, Jagiellonian University School of Medicine, Kraków, Poland.
Elzbieta DembowskaDepartment of Periodontology, Pomeranian Medical University, Szczecin, Poland.
Delyth GrahamInstitute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
David G HarrisonDepartment of Clinical Pharmacology, Vanderbilt University, Nashville, TN, USA.
Tomasz J GuzikInstitute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.ORCID 0000-0002-5039-7849
University of Glasgow · GBJagiellonian University · PLPomeranian Medical University · PLVanderbilt University · US

Funding

Mechanisms of Immune Activation in HypertensionR35HL140016 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI HARRISON, DAVID G · 2018 to 2024
$5.3M
British Heart Foundation RE/13/5/30177NHLBI NIH HHS R35 HL140016
6 · The paper itself

Abstract

background and purposeEmerging evidence indicates that hypertension is mediated by immune mechanisms. We hypothesized that exposure to Porphyromonas gingivalis antigens, commonly encountered in periodontal disease, can enhance immune activation in hypertension and exacerbate the elevation in BP, vascular inflammation and vascular dysfunction. EXPERIMENTAL APPROACH: Th1 immune responses were elicited through immunizations using P. gingivalis lysate antigens (10 μg) conjugated with aluminium oxide (50 μg) and IL-12 (1 μg). The hypertension and vascular endothelial dysfunction evoked by subpressor doses of angiotensin II (0.25 mg·kg KEY

resultsSystemic T-cell activation, a characteristic of hypertension, was exacerbated by P. gingivalis antigen stimulation. This translated into increased aortic vascular inflammation with enhanced leukocyte, in particular, T-cell and macrophage infiltration. The expression of the Th1 cytokines, IFN-γ and TNF-α, and the transcription factor, TBX21, was increased in aortas of P. gingivalis/IL-12/aluminium oxide-immunized mice, while IL-4 and TGF-β were unchanged. These immune changes in mice with induced T-helper-type 1 immune responses were associated with an enhanced elevation of BP and endothelial dysfunction compared with control mice in response to 2 week infusion of a subpressor dose of angiotensin II. CONCLUSIONS AND IMPLICATIONS: These results support the concept that Th1 immune responses induced by bacterial antigens such as P. gingivalis can increase sensitivity to subpressor pro-hypertensive insults such as low-dose angiotensin II, thus providing a mechanistic link between chronic infection, such as periodontitis, and hypertension. LINKED ARTICLES: This article is part of a themed section on Immune Targets in Hypertension. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v176.12/issuetoc.

Indexed as

Angiotensin IIAnimalsAntigens, BacterialDose-Response Relationship, DrugFlow CytometryHypertensionInflammationMaleMiceMice, Inbred C57BLPorphyromonas gingivalisTh1 CellsVentricular DysfunctionAngiotensin IIAntigens, Bacterial

Identifiers

PMID30414380
PMCPMC6534780
OpenAlexW2899545787

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.